Author Question: A researcher is investigating some of the behavioral properties of a new drug called GR1944 (a ... (Read 12 times)

jenna1

  • Hero Member
  • *****
  • Posts: 568
A researcher is investigating some of the behavioral properties of a new drug called GR1944 (a hypothetical drug).
 
  She trains two groups of rats on tasks in which bar pressing is occasionally reinforced with food. For GROUP DRLR rats the longer the interval between bar presses the greater the likelihood that a bar press will be rewarded, so GROUP DRLR rats generally press the bar fairly infrequently. For GROUP DRHR rats the shorter the interval between bar presses the greater the likelihood that a bar press will be rewarded, so GROUP DRHR rats press the bar fairly rapidly. After the two groups are trained over several daily sessions to the point that their responding is at stable levels, the researcher splits the two groups into two subgroups. For five successive daily test sessions, she injects GROUP DRLR-1 and GROUP DRHR-1 rats with 100 mg of GR1944 30 minutes prior to each session, and for five successive daily test sessions, she injects GROUP DRLR-2 and GROUP DRHR-2 rats with saline 30 minutes prior to each session. The researcher measures the rate of bar pressing for each group over the five test sessions.
  The researcher notes that after the first injection of GR1944, the GROUP DRLR-1 and GROUP DRHR-1 rats respond much more frequently than their counterpart controls (i.e., GROUPs DRLR-2 and DRHR-2). However, by the fifth test session, the GROUP DRLR-1 rats are responding at about the same level as the GROUP DRLR-2 rats, i.e., it appears that tolerance to GR1944 has occurred. On the other hand, by the fifth test session, the GROUP DRHR-1 rats are still responding much faster than the GROUP DRHR-2 rats, i.e., tolerance to GR1944 does not appear to have occurred.
  1. Are these observations more compatible with a pharmacodynamic or a context-specific mechanism for tolerance development? Explain your reasoning.
 
  What will be an ideal response?

Question 2

Which of the following is not included in the category of monoamine neurotransmitters?
 
  a. serotonin
  b. norepinephrine
  c. dopamine
  d. endorphins



debra928

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

Since both groups DRLR-1 and DRHR-1 were given the same amount of GR1944 over the same time intervals and only one group exhibited tolerance, a pharmacodynamic mechanism can be ruled out, leaving a context-specific mechanism resulting from the fact that the task requirements for the two groups of rats were very different. Specifically, group DRLR-1 rats would have lost reinforcers upon exposure to GR1944 because it resulted in them responding more frequently, whereas group DRHR-1 rats would likely increase their reinforcement rate with the drug because the responded even more rapidly than without the drug. Thus, one would predict that group DRLR-1 rats would learn some compensatory instrumental behaviors that resulted in them decreasing their rate of responding to reestablish their original rate of reinforcement, i.e., show tolerance. Since there would be nothing for group DRHR-1 rats to compensate for, they would show no tolerance.

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

Tobacco depletes the body of vitamins A, C, and E, which can result in any of the following: dry hair, dry skin, dry eyes, poor growth, night blindness, abscesses, insomnia, fatigue, reproductive system problems, sinusitis, pneumonia, frequent respiratory problems, skin disorders, weight loss, rickets, osteomalacia, nervousness, muscle spasms, leg cramps, extremity numbness, bone malformations, decayed teeth, difficulty in walking, irritability, restlessness, profuse sweating, increased uric acid (gout), joint damage, damaged red blood cells, destruction of nerves, infertility, miscarriage, and many types of cancer.

For a complete list of videos, visit our video library